Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer
<p>Abstract</p> <p>Background</p> <p>Myofibrillogenesis regulator 1 (MR-1) is overexpressed in human cancer cells and plays an essential role in cancer cell growth. However, the significance of MR-1 in human ovarian cancer has not yet been explored. The aim of this stud...
Main Authors: | Feng Jingjing, Sun Min, Lu Renquan, Gao Xiang, Guo Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-06-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/11/270 |
Similar Items
-
Mammalian formin Fhod3 plays an essential role in cardiogenesis by organizing myofibrillogenesis
by: Meikun Kan-O, et al.
Published: (2012-07-01) -
Assembly of the giant protein projectin during myofibrillogenesis in <it>Drosophila </it>indirect flight muscles
by: Bounaix Christophe, et al.
Published: (2004-04-01) -
Paroxysmal Nonkinesigenic Dyskinesia
by: J Gordon Millichap
Published: (2006-06-01) -
Asparagus officinalis Exhibits Anti-Tumorigenic and Anti-Metastatic Effects in Ovarian Cancer
by: Guangxu Xu, et al.
Published: (2021-07-01) -
Unravelling The Mechanisms Of Myofibrillogenesis And Human Myopathies Using Drosophila Mutants
by: Salvi, Sheetal S
Published: (2013)